- FDA’s New Efforts to Advance Biotechnology Innovation
- FDA Proposes Process Modernization to Support New Drug Development
- FDA Update on Traceback Related to the E. coli O157:H7 Outbreak Linked to Romaine Lettuce
- The FDA Issues Draft Guidance About the Absorption of Active Ingredients Being Considered for Inclusion in Over-the-Counter Drug Products Applied to the Skin and Marketed without Approved Applications
- Report Spotlights Achievements of FDA-Mexico Produce Safety Partnership
- FDA Budget Matters: Infrastructure to Support Robust Generic Drug Competition
- FDA Budget Matters: Investing in Advanced Domestic Manufacturing
- FDA Budget Matters: A Cross-Cutting Data Enterprise for Real World Evidence
- The American Chamber of Horrors
- Protecting and Promoting Public Health: Advancing the FDA’s Medical Countermeasures Mission
- FDA Announces Two Initiatives to Modernize Drug Quality Programs
- Advancing Tobacco Regulation to Protect Children and Families: Updates and New Initiatives from the FDA on the Anniversary of the Tobacco Control Act and FDA’s Comprehensive Plan for Nicotine
- FDA Advances Efficient Approaches to Designing and Conducting Cancer Clinical Trials
- FDA’s Comprehensive Effort to Advance New Innovations: Initiatives to Modernize for Innovation
- New Program with Payors Aims to Accelerate Patient Access to Medical Devices
- On-Farm Readiness Reviews Support Farmers as They Safeguard Produce